Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cognitive Dysfunction × Methylphenidate × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2 Gastrointestinal Neoplasms 1 Fatigue 1 Cognitive Dysfunction 1

Interventions

Transcranial Direct Current Stimulation 4 Walking 2 lime 1 Ultraviolet Therapy 1 Tai Ji 1 Sugars 1 Standard of Care 1 Sodium Chloride 1 Organization and Administration 1 Methylphenidate 1 Memantine 1 Low-Level Light Therapy 1 G(M1) Ganglioside 1 Drug Therapy 1 Donepezil 1 Docosahexaenoic Acids 1 Cognitive Training 1 Cognitive Behavioral Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02970500 2023-03-23

CogMet

CHU de Quebec-Universite Laval

Phase 2 Terminated

Breast Neoplasms, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡